Drug search by name

Omeprazole Delayed-Release Capsules and Tablets (OTC) and Bone fractures

Result of checking the interaction of drug Omeprazole Delayed-Release Capsules and Tablets (OTC) and disease Bone fractures for safety when used together.

Check result:

Omeprazole Delayed-Release Capsules and Tablets (OTC) <> Bone fractures

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Various published observational studies have reported that PPI therapy may be associated with an increased risk for osteoporosis related fractures of the hip, wrist or spine. The risk was increased in patients who received high doses (multiple daily doses), and long term treatment (a year or longer). Patients should use the lowest dose and shortest duration of PPI therapy appropriate to the condition being treated. Caution should be used in patients at risk for osteoporosis related fractures and should be managed according to established treatment guidelines.

Omeprazole Delayed-Release Capsules and Tablets (OTC)

Generic Name: omeprazole

Brand Name: FIRST Omeprazole, Omeprazole + SyrSpend SF Alka, Prilosec, Prilosec OTC, Zegerid>, Prilosec, Prilosec OTC

Synonyms: Omeprazole

What is Omeprazole Delayed-Release Capsules and Tablets (OTC)?